Clinical Utility of CTC-Based Monitoring of Late-Line Chemotherapy for Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Utility of Circulating Tumour Cell-Based Monitoring of Late-Line Chemotherapy for Metastatic Breast Cancer: The Randomised CirCe01 Trial
Br. J. Cancer 2021 Jan 21;[EPub Ahead of Print], L Cabel, F Berger, P Cottu, D Loirat, A Rampanou, E Brain, S Cyrille, H Bourgeois, N Kiavue, E Deluche, S Ladoire, M Campone, JY Pierga, FC BidardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.